Female Reproductive Tract Infections Among Vaginal Contraceptive Users in Benin City, Nigeria

Genomic Medicine, Biomarkers, and Health Sciences

Volumn 3, Issue 1, 2011, Pages 49-52

  Egbe, Christopher Aye ^a   Onwufor, Uchenna Chukwunweike ^a   Omoregie, Richard ^a   Enabulele, Onaiwu Idahosa ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Candida albicans; Female contraceptives; Nigeria; Reproductive tract infection

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATE; CANDIDA ALBICANS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; INFORMATION PROCESSING; INTRAUTERINE CONTRACEPTIVE DEVICE; KLEBSIELLA; MAJOR CLINICAL STUDY; NIGERIA; PHYSICAL DISEASE BY BODY FUNCTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; VAGINA CANDIDIASIS; VAGINA CONTRACEPTION; VAGINITIS;

EID: 80053000794     PISSN: 22114254     EISSN: 22114254     Source Type: Journal    
DOI: 10.1016/S2211-4254(11)60007-1     Document Type: Article

References (15)

1. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva, 2001.
2. Prasad SA, Kathleen MK, Valentina G, et al. Reproductive tract infections among young married women in Tamil Nadu, India. Int Fam Plann Perspect 2005, 31:73-82.
3. Aitken RJ, Baker MA, Doncel GF, et al. As the world grows: contraception in the 21st century. J Clin Invest 2008, 118:1330-1343.
4. Brabin L, Gogate A, Gogate S, et al. Reproductive tract infections, gynaecological morbidity and HIV seroprevalence among women in Mumbai, India. Bull WHO 1998, 76:277-287.
5. Pàl Z, Urban E, Dosa E, et al. Biofilm formation on intrauterine devices in relation to duration of use. J Med Micro 2005, 54:1199-1203.
6. Hawkes S, Morison L, Chakraborty J, et al. Reproductive tract infections: prevalence and risk factors in rural Bangladesh. Bull WHO 2002, 80:180-188.
7. Barrow GI, Feltham RKA Cowan and Steel's Manual for the Identification of Medical Bacteria 2003, Cambridge University Press, Cambridge, UK. 3rd edition.
8. Sharief M Genital infections among women using various contraceptive methods in Basra, Iraq. Eastern Mediterr Health 1998, 4:487-492.
9. Omoregie R, Egbe CA, Igbarumah IO, et al. Prevalence and etiologic agents of female reproductive tract infection among in-patients and out-patients of a tertiary hospital in Benin City, Nigeria. North Am J Med Sci 2010, 2:473-477.
10. Ghazal S, Musmar M, AL-Tell MAI Effect of IUD (intrauterine device) on reproductive tract infection (RTI) in the Northern West Bank. Middle East J Fam Med 2004, 2:1-12.
11. Sowmini CV, Sankara SP Reproductive morbidity among contraceptive users: need for quality services. J Fam Welfare 2004, 50:31-37.
12. Enomoto LM, Kloberdanz KJ, Mark DG, et al. Ex vivo effect of estrogen and progesterone compared with dexamethasone on cell-mediated immunity of HIV-infected and uninfected subjects. J Acquir Immun Defic Syndr 2007, 45:137-145.
13. Sobel JD Epidemiology and pathogenesis of recurrent vulvo-vaginal candidiasis. Am J Obstet Gynecol 1985, 152:924-934.
14. Paavonem J Physiology and ecology of the vagina. Scand J Infect Dis 1983, 40(Suppl):31-35.
15. Mahdi NK, Gany ZH, Sharief M Risk factors for vaginal trichomoniasis among women in Basra, Iraq. Eastern Mediterr Health J 2001, 7:918-924.